Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types

Overexpression of the chondroitin sulfate proteoglycan 4 (CSPG4) has been associated with the pathology of multiple types of such as melanoma, breast cancer, squamous cell carcinoma, mesothelioma, neuroblastoma, adult and pediatric sarcomas, and some hematological cancers. CSPG4 has been reported to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilieva, Kristina M., Cheung, Anthony, Mele, Silvia, Chiaruttini, Giulia, Crescioli, Silvia, Griffin, Merope, Nakamura, Mano, Spicer, James F., Tsoka, Sophia, Lacy, Katie E., Tutt, Andrew N. J., Karagiannis, Sophia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767725/
https://www.ncbi.nlm.nih.gov/pubmed/29375561
http://dx.doi.org/10.3389/fimmu.2017.01911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767725/
https://www.ncbi.nlm.nih.gov/pubmed/29375561
http://dx.doi.org/10.3389/fimmu.2017.01911

Ejemplares similares